Why is understanding the relationship of testosterone to cardiovascular risk so important?
暂无分享,去创建一个
[1] Effects of Testosterone Treatment in Older Men. , 2018, The New England journal of medicine.
[2] T. Jones,et al. Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system , 2018, Asian journal of andrology.
[3] Yi-qun Gu,et al. Testosterone replacement therapy: dilemmas and challenges in China and Asia , 2018, Asian journal of andrology.
[4] M. Zitzmann. Would male hormonal contraceptives affect cardiovascular risk? , 2018, Asian journal of andrology.
[5] G. Wittert,et al. Endogenous testosterone and mortality risk , 2018, Asian journal of andrology.
[6] B. Yeap. Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men , 2017, Asian journal of andrology.
[7] S. Basaria,et al. Trials of testosterone replacement reporting cardiovascular adverse events , 2017, Asian journal of andrology.
[8] C. Lewis,et al. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial , 2017, JAMA internal medicine.
[9] S. Sidney,et al. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency , 2017, JAMA internal medicine.
[10] H. Cohen,et al. Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial , 2017, JAMA internal medicine.
[11] S. Resnick,et al. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment , 2017, JAMA.
[12] M. Budoff,et al. Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone , 2017, JAMA.
[13] Sonal Singh,et al. Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. , 2016, The lancet. Diabetes & endocrinology.
[14] H. Burger,et al. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations , 2016, The Medical journal of Australia.
[15] H. Burger,et al. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy , 2016, The Medical journal of Australia.
[16] B. Dawn,et al. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. , 2015, European heart journal.
[17] R. Swerdloff,et al. Clinical decisions. Testosterone-replacement therapy. , 2014, The New England journal of medicine.
[18] J. B. Layton,et al. Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. , 2014, The Journal of clinical endocrinology and metabolism.
[19] G. Grunwald,et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. , 2013, JAMA.
[20] David Handelsman. Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse , 2013, The Medical journal of Australia.
[21] A. Araujo,et al. Do low testosterone levels contribute to ill-health during male ageing? , 2012, Critical reviews in clinical laboratory sciences.